Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma

Figure 1

TP53 mutational status in EC patients from TCGA dataset. (a) Kaplan–Meier (K-M) analysis confirmed that the patients with TP53 mutation have poor survival outcome. (b–e) TP53 mutation was related to poor outcome, older age, lower BMI, and higher levels of grade and stage of patients with EC.

(a)

(b)

(c)

(d)

(e)